Pomalidomide, Dexamethasone, & Elotuzumab Combo Trial

Pomalidomide, Dexamethasone, & Elotuzumab Combo Trial

User Photo
ASHReport

1 year
137 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Sundar Jagannath, M.D. Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute Discusses Pomalidomide, Dexamethasone, & Elotuzumab Combo Trial At The 60th ASH Annual Meeting on Dec 1, 2018.
Up Next Autoplay